ArticleNature communications2026

A dihydrouracil CRBN ligand mitigates IMiD associated safety liabilities in heterobifunctional targeted protein degrader.

Monica C Rodrigo-Brenni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.